Polaris Venture Management Co. V as of March 31, 2018
Portfolio Holdings for Polaris Venture Management Co. V
Polaris Venture Management Co. V holds 11 positions in its portfolio as reported in the March 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Arsanis | 24.4 | $43M | 1.9M | 22.89 | |
| Cardlytics (CDLX) | 22.0 | $39M | 2.6M | 14.63 | |
| Kala Pharmaceuticals | 16.8 | $29M | 1.9M | 15.83 | |
| Fate Therapeutics (FATE) | 13.8 | $24M | 2.5M | 9.76 | |
| Selecta Biosciences (RNAC) | 9.3 | $16M | 1.6M | 10.19 | |
| T2 Biosystems | 6.9 | $12M | 1.9M | 6.49 | |
| Atyr Pharma Inc Common Stock Usd 0.001 | 2.8 | $4.8M | 1.8M | 2.65 | |
| Trevena | 1.9 | $3.4M | 2.1M | 1.64 | |
| Genocea Biosciences | 1.2 | $2.1M | 2.0M | 1.05 | |
| Pulmatrix | 0.8 | $1.4M | 2.8M | 0.51 | |
| Dare Bioscience (DARE) | 0.2 | $274k | 326k | 0.84 |
